CTLA-4 (monomer, short)
Use this icon in our BioRender software along with 1000s of others. Create your next scientific figure in minutes!
SIGN UP FREE[{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f82b/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f82b/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f82a/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f82a/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f829/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f829/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f828/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f828/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f827/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f827/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f826/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f826/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f825/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f825/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f824/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f824/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f823/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f823/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f822/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f822/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f821/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f821/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f820/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f820/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f81f/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f81f/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f81e/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f81e/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f81d/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f81d/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f81c/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f81c/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f81b/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f81b/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f81a/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f81a/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f819/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f819/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f818/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f818/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f817/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f817/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f816/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f816/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f815/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f815/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f814/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f814/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f813/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f813/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f812/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f812/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f811/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f811/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f810/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f810/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f80f/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f80f/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f80e/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f80e/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f80d/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f80d/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f80c/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f80c/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f80b/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f80b/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f80a/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f80a/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f809/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f809/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f808/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f808/ctla-4-monomer-short.png"},{"image":"https://icons.biorender.com/w75xh75/6333120ad8c4400021f6f807/ctla-4-monomer-short.png","waterMarkImage":"https://icons.biorender.com/w550xh620/6333120ad8c4400021f6f807/ctla-4-monomer-short.png"}]
Keywords
CTLA4,CTLA-4,CD152,cytotoxic t-lymphocyte associated 4,ALPS4,CELIAC3,GRD4,GSE,IDDM12,immune checkpoint,t-cell,T cell,APC,CD89,CD86,short,monomer,CTLA4,CTLA-4